Erectile dysfunction in hyperuricemia: A prevalence meta‐analysis and meta‐regression study
| العنوان: | Erectile dysfunction in hyperuricemia: A prevalence meta‐analysis and meta‐regression study |
|---|---|
| المؤلفون: | Maria Totaro, Chiara Castellini, Daniele Tienforti, Sotirios Dimarakis, Marco Giorgio Baroni, Arcangelo Barbonetti, Federica D’Amato, Sara Palazzi, Settimio D'Andrea, Sandro Francavilla, Antonio Parisi |
| المصدر: | Andrology. 10:72-81 |
| بيانات النشر: | Wiley, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Adult, Male, medicine.medical_specialty, Funnel plot, Urology, Endocrinology, Diabetes and Metabolism, impotence, sexual function, Hyperuricemia, metabolic syndrome, gout, Endocrinology, uric acid, Erectile Dysfunction, Risk Factors, Internal medicine, Prevalence, medicine, Humans, diabetes, business.industry, Penile Erection, Type 2 Diabetes Mellitus, Publication bias, Middle Aged, medicine.disease, Confidence interval, Erectile dysfunction, Diabetes Mellitus, Type 2, Reproductive Medicine, Meta-analysis, Regression Analysis, Metabolic syndrome, business |
| الوصف: | BACKGROUND Whether and to what extent an association exists between hyperuricemia and erectile dysfunction (ED) has not yet been fully determined. OBJECTIVE To define pooled prevalence estimates and correlates of erectile dysfunction in men with hyperuricemic disorders. MATERIALS AND METHODS A thorough search of Medline, Scopus, and Cochrane Library databases was performed. Data were combined using random-effects models and the between-study heterogeneity was assessed by Cochrane's Q and I2 tests. A funnel plot was used to assess publication bias. RESULTS Overall, 8 studies included gave information about 85,406 hyperuricemic men, of whom 5023 complained of erectile dysfunction, resulting in a pooled erectile dysfunction prevalence estimate of 33% (95% Confidence Interval: 13-52%; I² = 99.9%). The funnel plot suggested the presence of a publication bias. At the meta-regression analyses, among the available covariates that could affect estimates, only type 2 diabetes mellitus was significantly associated with a higher prevalence of erectile dysfunction (β = 0.08; 95% Confidence Interval: 0.01, 0.15, p = 0.025). At the sub-group analysis, the pooled erectile dysfunction prevalence decreased to 4% (95% Confidence Interval: 0%-8%) when only the largest studies with the lowest prevalence of type 2 diabetes mellitus were included and increased up to 50% (95% Confidence Interval: 17%-84%) when the analysis was restricted to studies enrolling smaller series with higher prevalence of type 2 diabetes mellitus. CONCLUSIONS A not negligible proportion of men with hyperuricemia can complain of erectile dysfunction. While a pathogenetic contribution of circulating uric acid in endothelial dysfunction cannot be ruled out, the evidence of a stronger association between hyperuricemia and erectile dysfunction in type 2 diabetes mellitus points to hyperuricemia as a marker of systemic dysmetabolic disorders adversely affecting erectile function. |
| تدمد: | 2047-2927 2047-2919 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6ff4a99659eab5e4f88218a7a263964 https://doi.org/10.1111/andr.13088 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....d6ff4a99659eab5e4f88218a7a263964 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 20472927 20472919 |
|---|